Gordon N F, van Rensburg J P, Russell H M, Kielblock A J, Myburgh D P
Int J Sports Med. 1987 Feb;8(1):1-5. doi: 10.1055/s-2008-1025631.
The effect of clinically used doses of propranolol, atenolol, nifedipine, propranolol plus nifedipine, and atenolol plus nifedipine on thermoregulatory responses of 11 healthy men was studied during 2-h block-stepping in heat. Drug intervention did not alter ventilation during exercise. In contrast, propranolol and atenolol produced equivalent reductions in exercise tachycardia, implying a similar level of beta 1-adrenoceptor blockade. The heart rate response to exercise was unaffected by nifedipine and during dual beta-adrenoceptor blockade and calcium antagonism was equivalent to that with beta-adrenoceptor blockade alone. While rectal temperature rises were not modified by drug ingestion, propranolol and, to a lesser degree, atenolol and combination therapy, but not nifedipine alone, attenuated skin temperature rises. Moreover, although atenolol, nifedipine, and their combination did not alter sweating, propranolol and its combination with nifedipine enhanced sweating during the 1st and 2nd h of exercise. This study concludes that nifedipine does not modify thermoregulation during exercise and allows for greater confidence of its use during cardiac rehabilitation. Furthermore, the present data confirm that propranolol does enhance sweating during exercise and demonstrate that this effect is not mediated simply by an earlier onset of rapid sweating nor abolished by concomitant calcium antagonism.
研究了临床使用剂量的普萘洛尔、阿替洛尔、硝苯地平、普萘洛尔加硝苯地平以及阿替洛尔加硝苯地平对11名健康男性在热环境中进行2小时阶梯式踏步运动时体温调节反应的影响。药物干预未改变运动期间的通气情况。相比之下,普萘洛尔和阿替洛尔对运动性心动过速的降低程度相当,这意味着β1 -肾上腺素能受体阻滞水平相似。硝苯地平对运动时的心率反应无影响,在双重β -肾上腺素能受体阻滞和钙拮抗作用期间,心率反应与单独的β -肾上腺素能受体阻滞时相当。虽然药物摄入未改变直肠温度升高,但普萘洛尔以及程度较轻的阿替洛尔和联合治疗可减弱皮肤温度升高,而单独使用硝苯地平则无此作用。此外,尽管阿替洛尔、硝苯地平及其联合用药未改变出汗情况,但普萘洛尔及其与硝苯地平的联合用药在运动的第1小时和第2小时增强了出汗。本研究得出结论,硝苯地平在运动期间不改变体温调节,这使得在心脏康复期间使用它更具信心。此外,目前的数据证实普萘洛尔在运动期间确实会增强出汗,并表明这种作用并非仅仅由快速出汗的提前开始介导,也不会因同时使用钙拮抗剂而消除。